Belatacept Evaluation of Nephroprotection and Efficacy a

Project: Research project

Project Details

Description

Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immuno-suppression Trial - EXTended Criteria Donors (Benefit - EXT)
StatusFinished
Effective start/end date11/1/0412/1/15

Funding

  • BRISTOL-MYERS SQUIBB PHARM RES

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.